aspiration during anesthesia semaglutide case report 2023 Health Rounds: No need to stop GLP-1 drugs before surgery for most patients case report aspiration anesthesia semaglutide

Cutaneous adverse events (CAEs) to GLP-1 agonists were retrospectively reviewed using the FDA Adverse Event Reporting System (FAERS)

While the medication has proven effective for many, some users report experiencing hair thinning or loss after starting treatment

This is significant because the available therapies for lowering ICP often exacerbate existing cognitive deficits

doi: 10.1038/nature13540

The future of incretins and new agents Incretin analogues have proven to be very popular, with global shortages precipitated by high demand, which has been particularly problematic for patients

In recent years, synthetic peptides have been developed to mimic those naturally occurring in the organism